The group of Antonio Pineda-Lucena specializes in Nuclear Magnetic Resonance spectroscopy methods for pharmaceutical and biomedical research. The group employs several drug discovery protocols based on NMR, metabolomic profiling for disease and develops new NMR screening and monitoring protocols to investigate drug metabolism.